Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-08-24 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司2023年半年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from a sponsoring institution (中信证券股份有限公司) regarding the special audit opinion on the storage and use of raised funds for Shenzhen Huitai Medical Device Co., Ltd. for the half-year period of 2023. It includes detailed financial figures about the raised funds, their usage, management, and compliance with regulatory requirements. The document references regulatory guidelines and laws related to the management and use of raised funds, and it contains extensive financial data and tables about the funds' usage and storage. This type of document is a specialized audit report focusing on the use of raised capital, not a full annual or interim report, nor a simple announcement. It fits the category of an Audit Report / Information (AR) as it is a standalone audit opinion on a specific financial aspect (fundraising and usage) for a half-year period, with detailed financial data and regulatory compliance information. H1 2023
2023-08-24 Chinese
第二届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shenzhen Huitai Medical Devices Co., Ltd. It discusses the approval of the company's 2023 semi-annual report and a special report on the use of raised funds for the same period. The document states that the actual reports are disclosed on the Shanghai Stock Exchange website and does not contain the full financial data or detailed report content itself. The document length is short (1160 characters) and serves as an announcement of the meeting resolutions and references the actual reports elsewhere. Therefore, it fits the category of a Regulatory Filing (RNS) rather than the full Interim/Quarterly Report (IR) or Annual Report (10-K).
2023-08-24 Chinese
2023年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a '2023 半年度报告摘要' which translates to '2023 Semi-Annual Report Summary'. It contains detailed financial data for the half-year period, including total assets, net profit, revenue, earnings per share, and shareholder information. The document explicitly states it is a half-year report summary and references the full half-year report for comprehensive details. The length of the document (8572 characters) and the presence of substantive financial data and analysis confirm it is a financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-24 Chinese
2023年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2023年半年度募集资金存放与实际使用情况的专项报告" which translates to "2023 Semi-Annual Special Report on the Deposit and Actual Use of Raised Funds." It details the use and management of funds raised through a public stock issuance, including amounts raised, usage, storage, and investment of idle funds. The document references regulatory approvals and compliance with securities regulations. It is a comprehensive report on the use of capital raised by the company during a half-year period, containing detailed financial figures and project investment updates. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital usage. The document is not an announcement of a report but the report itself, and it is not a general regulatory filing or announcement. Therefore, the correct classification is CAP with high confidence.
2023-08-24 Chinese
关于召开2023年半年度业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the scheduling and details of a 2023 half-year performance explanation meeting (业绩说明会) for Shenzhen Huitai Medical Device Co., Ltd. It specifies the date, time, location, and participation method for the meeting, which is intended to discuss the company's 2023 half-year operating results and financial indicators. The document does not contain actual financial statements or detailed financial analysis but rather informs investors about the upcoming event where such information will be discussed. This matches the characteristics of an Investor Presentation (IP) or a Call Transcript (CT) if it were a transcript, but since this is an announcement of the meeting itself and not the transcript or presentation content, it is best classified as an Investor Presentation (IP) because the meeting is described as a performance explanation session with interactive Q&A, typical of investor presentations. The document length is short (1493 characters), but it is not merely announcing the release of a report; it is announcing the meeting to discuss the half-year results. Therefore, the best fit is Investor Presentation (IP).
2023-08-22 Chinese
公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Shenzhen Huitai Medical Devices Co., Ltd. It includes comprehensive sections on company organization, share issuance, shareholder rights, board and management structure, financial accounting, profit distribution, internal audit, and procedures for shareholder meetings. It references Chinese company law, securities law, and stock exchange listing rules. The content is legal and governance-focused, detailing the internal rules and governance practices of the company rather than financial results, audit opinions, or meeting announcements. It is not a report of financial performance, nor an announcement or transcript. The document is lengthy (15,000 characters) and substantive, not a brief notice or certification. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-07-03 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.